Summary
IDEXX Laboratories, Inc. (IDXX) filed a Form 8-K on November 1, 2022, to report its financial results for the third quarter ended September 30, 2022. The filing primarily serves as a notification of the earnings release, which is furnished as an exhibit. Investors should refer to the press release (Exhibit 99.1) for detailed financial performance and operational updates for the quarter. This report itself does not contain the specific financial figures but points investors to the official announcement for that information.
Key Highlights
- 1IDEXX Laboratories announced its third quarter 2022 financial results on November 1, 2022.
- 2The primary purpose of this 8-K filing is to furnish the earnings press release.
- 3The press release (Exhibit 99.1) contains the detailed financial results for the quarter ended September 30, 2022.
- 4Information furnished under Item 2.02 is not considered 'filed' for certain regulatory purposes, limiting liability under specific sections of the Exchange Act.
- 5Investors are directed to the attached press release for all substantive financial and operational information.
- 6The filing includes the cover page interactive data file as an exhibit.